The US FDA ‘Black Box’ Warning for Topical Calcineurin Inhibitors Johannes RingMatthias MöhrenschlagerVerena Henkel Current Opinion 03 January 2013 Pages: 185 - 198
Drug-Induced Taste Disorders Richard L. DotyMuhammad ShahSteven M. Bromley Review Article 03 January 2013 Pages: 199 - 215
A Benefit-Risk Review of Systemic Haemostatic Agents Ian S. FraserRobert J. PorteAndrea S. Lukes Review Article 03 January 2013 Pages: 217 - 230
Frequency and Clinical Relevance of Drug Interactions with Lovastatin and Simvastatin Tuire TirkkonenAnna RyynänenKari Laine Original Research Article 03 January 2013 Pages: 231 - 240
Post-Marketing Surveillance of Ischaemic Optic Neuropathy in Male Veterans Co-Prescribed Phosphodiesterase-5 Inhibitors with Organic Nitrates or α-Blockers Dustin D. FrenchCurtis E. Margo Original Research Article 03 January 2013 Pages: 241 - 247
Improving the Detection of Subtle IKr-Inhibition Jean-Philippe CoudercScott McNittWojciech Zareba Original Research Article 03 January 2013 Pages: 249 - 260
Use of Over-the-Counter Analgesics in Patients with Chronic Liver Disease Simona RossiDavid N. AssisVictor J. Navarro Original Research Article 03 January 2013 Pages: 261 - 270
The ‘Power’ of Signal-Detection Algorithms M. Rezaul KarimStephen L. KlincewiczChuen L. Yee Correspondence 03 January 2013 Pages: 271 - 272
The Authors’ Reply Yasuyuki MatsushitaYasufumi KurodaIsao Yoshimura Correspondence 03 January 2013 Pages: 272 - 273